• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全外显子组测序揭示原发性与配对复发性三阴性乳腺癌之间的高突变一致性。

Whole-Exome Sequencing Reveals High Mutational Concordance between Primary and Matched Recurrent Triple-Negative Breast Cancers.

作者信息

Kaur Jaspreet, Chandrashekar Darshan S, Varga Zsuzsanna, Sobottka Bettina, Janssen Emiel, Gandhi Khanjan, Kowalski Jeanne, Kiraz Umay, Varambally Sooryanarayana, Aneja Ritu

机构信息

Department of Biology, Georgia State University, Atlanta, GA 30303, USA.

Department of Pathology-Molecular and Cellular, University of Alabama at Birmingham, Birmingham, AL 35233, USA.

出版信息

Genes (Basel). 2023 Aug 25;14(9):1690. doi: 10.3390/genes14091690.

DOI:10.3390/genes14091690
PMID:37761830
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10531222/
Abstract

PURPOSE

Triple-negative breast cancer (TNBC) is a molecularly complex and heterogeneous breast cancer subtype with distinct biological features and clinical behavior. Although TNBC is associated with an increased risk of metastasis and recurrence, the molecular mechanisms underlying TNBC metastasis remain unclear. We performed whole-exome sequencing (WES) analysis of primary TNBC and paired recurrent tumors to investigate the genetic profile of TNBC.

METHODS

Genomic DNA extracted from 35 formalin-fixed paraffin-embedded tissue samples from 26 TNBC patients was subjected to WES. Of these, 15 were primary tumors that did not have recurrence, and 11 were primary tumors that had recurrence (nine paired primary and recurrent tumors). Tumors were analyzed for single-nucleotide variants and insertions/deletions.

RESULTS

The tumor mutational burden (TMB) was 7.6 variants/megabase in primary tumors that recurred ( = 9); 8.2 variants/megabase in corresponding recurrent tumors ( = 9); and 7.3 variants/megabase in primary tumors that did not recur ( = 15). was the most frequently mutated gene in all groups. Mutations in and were more common in our dataset. No alterations in were detected in our dataset.

CONCLUSIONS

We found similar mutational profiles between primary and paired recurrent tumors, suggesting that genomic features may be retained during local recurrence.

摘要

目的

三阴性乳腺癌(TNBC)是一种分子复杂且异质性的乳腺癌亚型,具有独特的生物学特征和临床行为。尽管TNBC与转移和复发风险增加相关,但其转移的分子机制仍不清楚。我们对原发性TNBC和配对的复发性肿瘤进行了全外显子测序(WES)分析,以研究TNBC的基因谱。

方法

从26例TNBC患者的35份福尔马林固定石蜡包埋组织样本中提取基因组DNA,进行WES分析。其中,15例为未复发的原发性肿瘤,11例为已复发的原发性肿瘤(9对原发性和复发性肿瘤)。对肿瘤进行单核苷酸变异和插入/缺失分析。

结果

复发的原发性肿瘤的肿瘤突变负荷(TMB)为7.6个变异/兆碱基(n = 9);相应复发性肿瘤的TMB为8.2个变异/兆碱基(n = 9);未复发的原发性肿瘤的TMB为7.3个变异/兆碱基(n = 15)。TP53是所有组中最常发生突变的基因。在我们的数据集中,PIK3CA和AKT1的突变更为常见。在我们的数据集中未检测到BRCA1和BRCA2的改变。

结论

我们发现原发性肿瘤和配对的复发性肿瘤之间具有相似的突变谱,这表明基因组特征在局部复发过程中可能得以保留。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dd6/10531222/9e1634c05af2/genes-14-01690-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dd6/10531222/cbdd6f81aa04/genes-14-01690-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dd6/10531222/3c517ab9a1b4/genes-14-01690-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dd6/10531222/9e1634c05af2/genes-14-01690-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dd6/10531222/cbdd6f81aa04/genes-14-01690-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dd6/10531222/3c517ab9a1b4/genes-14-01690-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dd6/10531222/9e1634c05af2/genes-14-01690-g003.jpg

相似文献

1
Whole-Exome Sequencing Reveals High Mutational Concordance between Primary and Matched Recurrent Triple-Negative Breast Cancers.全外显子组测序揭示原发性与配对复发性三阴性乳腺癌之间的高突变一致性。
Genes (Basel). 2023 Aug 25;14(9):1690. doi: 10.3390/genes14091690.
2
Comprehensive Analysis of the Immunogenomics of Triple-Negative Breast Cancer Brain Metastases From LCCC1419.来自LCCC1419的三阴性乳腺癌脑转移免疫基因组学的综合分析。
Front Oncol. 2022 Jul 27;12:818693. doi: 10.3389/fonc.2022.818693. eCollection 2022.
3
Tumor mutational profile of triple negative breast cancer patients in Thailand revealed distinctive genetic alteration in chromatin remodeling gene.泰国三阴性乳腺癌患者的肿瘤突变谱显示染色质重塑基因存在独特的基因改变。
PeerJ. 2019 Feb 25;7:e6501. doi: 10.7717/peerj.6501. eCollection 2019.
4
Analysis of the genomic landscapes of Barbadian and Nigerian women with triple negative breast cancer.巴巴多斯和尼日利亚三阴性乳腺癌女性的基因组景观分析。
Cancer Causes Control. 2022 Jun;33(6):831-841. doi: 10.1007/s10552-022-01574-x. Epub 2022 Apr 6.
5
Comprehensive Profiling of Poor-Risk Paired Primary and Recurrent Triple-Negative Breast Cancers Reveals Immune Phenotype Shifts.全面分析贫困风险原发性和复发性三阴性乳腺癌配对样本揭示免疫表型转变。
Clin Cancer Res. 2020 Feb 1;26(3):657-668. doi: 10.1158/1078-0432.CCR-19-1773. Epub 2019 Oct 14.
6
Comparison of triple-negative breast cancer molecular subtyping using RNA from matched fresh-frozen versus formalin-fixed paraffin-embedded tissue.使用配对的新鲜冷冻组织与福尔马林固定石蜡包埋组织的RNA对三阴性乳腺癌分子亚型进行比较。
BMC Cancer. 2017 Apr 4;17(1):241. doi: 10.1186/s12885-017-3237-1.
7
Whole exome sequencing (WES) on formalin-fixed, paraffin-embedded (FFPE) tumor tissue in gastrointestinal stromal tumors (GIST).对胃肠道间质瘤(GIST)的福尔马林固定、石蜡包埋(FFPE)肿瘤组织进行全外显子组测序(WES)。
BMC Genomics. 2015 Nov 3;16:892. doi: 10.1186/s12864-015-1982-6.
8
Distinct Gene Expression Profiles of Matched Primary and Metastatic Triple-Negative Breast Cancers.配对的原发性和转移性三阴性乳腺癌的不同基因表达谱
Cancers (Basel). 2022 May 16;14(10):2447. doi: 10.3390/cancers14102447.
9
Mutational profiles in triple-negative breast cancer defined by ultradeep multigene sequencing show high rates of PI3K pathway alterations and clinically relevant entity subgroup specific differences.通过超深度多基因测序确定的三阴性乳腺癌突变谱显示PI3K通路改变的发生率很高,且存在临床相关的实体亚组特异性差异。
Oncotarget. 2014 Oct 30;5(20):9952-65. doi: 10.18632/oncotarget.2481.
10
Clinical genomic profiling to identify actionable alterations for very early relapsed triple-negative breast cancer patients in the Chinese population.对中国人群中非常早期复发的三阴性乳腺癌患者进行临床基因组分析,以鉴定可采取行动的改变。
Ann Med. 2021 Dec;53(1):1358-1369. doi: 10.1080/07853890.2021.1966086.

引用本文的文献

1
Genomic characterization and molecular predictive biomarkers for chemotherapy in patients with metastatic triple-negative breast cancer treated in a real-world setting.真实世界中转移性三阴性乳腺癌患者化疗的基因组特征及分子预测生物标志物
Breast. 2025 Feb;79:103874. doi: 10.1016/j.breast.2025.103874. Epub 2025 Jan 2.
2
The Mutational Spectrum of Pre- and Post-Neoadjuvant Chemotherapy Triple-Negative Breast Cancers.新辅助化疗前后三阴性乳腺癌的突变谱。
Genes (Basel). 2023 Dec 23;15(1):27. doi: 10.3390/genes15010027.

本文引用的文献

1
Concordance of Genomic Variants in Matched Primary Breast Cancer, Metastatic Tumor, and Circulating Tumor DNA: The MIRROR Study.原发性乳腺癌、转移性肿瘤和循环肿瘤DNA中基因组变异的一致性:MIRROR研究
JCO Precis Oncol. 2019 Dec;3:1-16. doi: 10.1200/PO.18.00263.
2
Functional Genomic Analysis of Breast Cancer Metastasis: Implications for Diagnosis and Therapy.乳腺癌转移的功能基因组分析:对诊断和治疗的启示
Cancers (Basel). 2021 Jun 30;13(13):3276. doi: 10.3390/cancers13133276.
3
Genomic and Transcriptomic Analyses of Breast Cancer Primaries and Matched Metastases in AURORA, the Breast International Group (BIG) Molecular Screening Initiative.
AURORA 研究:乳腺癌原发灶和转移灶的基因组和转录组分析——乳腺国际集团(BIG)分子筛选计划
Cancer Discov. 2021 Nov;11(11):2796-2811. doi: 10.1158/2159-8290.CD-20-1647. Epub 2021 Jun 28.
4
Overview of recent advances in metastatic triple negative breast cancer.转移性三阴性乳腺癌的近期进展概述
World J Clin Oncol. 2021 Mar 24;12(3):164-182. doi: 10.5306/wjco.v12.i3.164.
5
Falco: high-speed FastQC emulation for quality control of sequencing data.Falco:用于测序数据质量控制的高速 FastQC 仿真。
F1000Res. 2019 Nov 7;8:1874. doi: 10.12688/f1000research.21142.2. eCollection 2019.
6
Resistance Mechanisms of Anti-PD1/PDL1 Therapy in Solid Tumors.实体瘤中抗PD1/PDL1治疗的耐药机制
Front Cell Dev Biol. 2020 Jul 21;8:672. doi: 10.3389/fcell.2020.00672. eCollection 2020.
7
Gene expression profiling identified TP53PIK3CA as a potential biomarker for patients with triple-negative breast cancer treated with immune checkpoint inhibitors.基因表达谱分析确定TP53PIK3CA为接受免疫检查点抑制剂治疗的三阴性乳腺癌患者的潜在生物标志物。
Oncol Lett. 2020 Apr;19(4):2817-2824. doi: 10.3892/ol.2020.11381. Epub 2020 Feb 10.
8
Differentially Expressed Genes in Matched Normal, Cancer, and Lymph Node Metastases Predict Clinical Outcomes in Patients With Breast Cancer.配对的正常组织、癌组织和淋巴结转移灶中的差异表达基因可预测乳腺癌患者的临床结局。
Appl Immunohistochem Mol Morphol. 2020 Feb;28(2):111-122. doi: 10.1097/PAI.0000000000000717.
9
Distinct gene expression profiles between primary breast cancers and brain metastases from pair-matched samples.原发性乳腺癌与配对样本脑转移瘤之间的基因表达谱存在明显差异。
Sci Rep. 2019 Sep 16;9(1):13343. doi: 10.1038/s41598-019-50099-y.
10
Risk factors for distant metastasis of patients with primary triple-negative breast cancer.原发性三阴性乳腺癌患者远处转移的危险因素。
Biosci Rep. 2019 Jun 4;39(6). doi: 10.1042/BSR20190288. Print 2019 Jun 28.